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Spondias mombin L. used in traditional medicine because of its antimicrobial properties was found to 
contain cardiac glycosides, flavonoids, tannins, and anthraquinones in the stem bark. Bioassay-
directed fractionation of the methanol extract of S. mombin was carried out with VLC and HPLC. 
Isolates were evaluated for antimtb activity which led to the isolation of a series of potential molecules. 
A semi pure triterpenoid that demonstrated potency of 92.8% inhibition against Mycobaterium 
tuberculosis (Mtb) at a concentration of 64 g/ml was further purified by HPLC.  
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INTRODUCTION 
 
Spondias mombin L. plant tree is erect, stately, to 65 ft 
(20 m) tall, with trunk somewhat buttressed and thick 
bark; often, in young trees, bearing many blunt-pointed 
spines or knobs. The fruit is aromatic, ovoid or oblong, 
golden-yellow; with thin, tough skin, and medium-yellow, 
clinging to the white, fibrous or "corky" stone. The tree is 
widely cultivated and naturalized in tropical Africa. Ripe 
fruits are eaten out-of-hand, or stewed with sugar. The 
extracted juice is used to prepare ice cream, cool 
beverages and jelly. Young leaves are cooked as greens. 
The fruit juice is drunk as a diuretic and febrifuge. The 
decoction of the astringent bark serves as an emetic, a 
remedy for diarrhea, dysentery, hemorrhoids and a 
treatment for gonorrhea and leucorrhea; and, in Mexico, it 
is believed to expel calcifications from the bladder. The 
powdered bark is applied on wounds (Morton, 1987). 
A tea of the flowers and leaves is taken to relieve 
stomachache, biliousness, urethritis, cystitis and eye and 
throat inflammation. The juice of crushed leaves and the 
powder of dried leaves are used as poultices on wounds 
and inflammations. The gum is employed as an expec-
torant and to expel tapeworms.  
Our antimtb screening of plant products from Nigeria 
resulted in S. mombin with a high potency in vitro activity 
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against mycobacterium tuberculosis. Tuberculosis is a 
common and often deadly infectious disease caused by 
Mycobacterium tuberculosis (Kumar et al., 2007). Anti-
biotic resistance remains a growing problem in multi-drug 
resistant tuberculosis (WHO, 2006). The emergence of 
multidrug-resistant tuberculosis (MDRTB) represents a 
large and growing threat to TB control programs. In 2004, 
mortality and morbidity statistics included 14.6 million 
chronic active cases, 8.9 million new cases, and 1.6 
million deaths, mostly in developing countries (WHO, 
2006). In addition, a rising number of people in the deve-
loped world are contracting tuberculosis because their 
immune systems are compromised by immunosup-
pressive drugs, substance abuse, or AIDS. According to 
Centers for Disease Control, 8 million people become ill 
with tuberculosis annually, and 2 million people die from 
the disease worldwide (CDC, 2006). Tuberculosis 
Research Scientists tackle important problems in the 
development of resistance to specific drugs such as 
pyrazinamide, isoniazid, and PA-824. So, there is an 
urgent need for drugs to combat the multidrug-resistant 
tuberculosis. 
 
 
MATERIALS AND METHODS 
 
General 
 
All chemicals were of analytical grade. Millipore water was collected  
1808         Afr. J. Biotechnol. 
 
 
 
from a Millipre Millipack® Express, 0.22 m water purifier (Millipore; 
Billerica, MA, USA). Phytochemical screening of methanol extract 
was carried out by the standard procedures (Harbone, 1998). 
Triterpenoids were detected by Liebermann-Burchard test which 
gave a characteristic blue-green colour. Vacuum liquid chromato-
graphy (VLC) was performed on Si gel (230-400 mesh-Merck). VLC 
on Si gel was carried out with gradient elution using hexane, 
EtOAc, MeOH and water in the order of increasing polarity. 
Preparative HPLC was performed with a waters Prep LC system. 
High resolution mass spectra were run on the Bruker ESI-
micrOTOF in positive mode coupled with an Agilent HPLC. 
 
 
Plant material  
 
The fresh plant material was collected from Ibadan, Oyo State, 
Nigeria in August, 2007.  Voucher specimen has been deposited in 
the Forestry Research Institute of Nigeria, Ibadan (FHI no. 107896). 
 
 
Extraction and Isolation    
 
Plant cold extraction was carried out with MeOH and the extract 
was evaporated in vacuo (yield: 3.7%). Bioassay guided fractiona-
tion of the crude extract was done by VLC using normal phase 
conditions. VLC on Si gel was carried out with gradient elution 
using hexane, EtOAc, MeOH and water in the order of increasing 
polarity. The active portion was further fractionated by HPLC (Luna 
C8 column 21.2 x 250 mm) using water, acetonitrile and methanol 
as eluents with flow rate 15 ml/min. A total of 22 fractions were 
collected and submitted for antiMtb assay. One of the active 
fractions: SMi15 (ACN/MeOH 78:22) was subjected to further 
purification by reversed-phase HPLC with C18 10 x 250 mm; 
ACN/MeOH (90:10-100) flow rate 3 ml/min which gave rise to 5 
metabolites. Isolates SMi-15-4 and SMi-15-5 were selected for 
characterization. 
 
 
Antibacterial assay  
 
A microplate-based assay which uses Alamar blue reagent for 
determination of growth was used. Percent inhibition of fraction 
agents against M. tuberculosis H37Rv was determined in the 
microplate Alamar blue assay (MABA) (Collins and Franzblau, 
1997; Franzblau et al., 1998).  
Antimicrobial susceptibility testing was performed in black, clear-
bottomed, 96-well microplates (black view plates; Packard Instru-
ment Company, Meriden, Conn.) in order to minimize background 
fluorescence. Outer perimeter wells were filled with sterile water to 
prevent dehydration in experimental wells. Initial drug dilutions were 
prepared in either dimethyl sulfoxide or distilled deionized water, 
and subsequent twofold dilutions were performed in 0.1 ml of 
7H9GC (no Tween 80) in the microplates. BACTEC 12B-passaged 
inocula were initially diluted 1:2 in 7H9GC, and 0.1 ml was added to 
wells. Subsequent determination of bacterial titers yielded 1 x 106 
CFU/ml in plate wells for H37Rv. Frozen inocula were initially 
diluted 1:20 in BACTEC 12B medium followed by a 1:50 dilution in 
7H9GC. Addition of 1/10 ml to wells resulted in final bacterial titers 
of 2.0 x 105 CFU/ml. 
Wells containing drug only were used to detect autofluorescence 
of compounds. Additional control wells consisted of bacteria only 
(B) and medium only (M). Plates were incubated at 37°C. Starting 
at day 4 of incubation, 20 ml of 103 alamarBlue solution (Alamar 
Biosciences/Accumed, Westlake, Ohio) and 12.5 ml of 20% Tween 
80 were added to one B well and one M well, and plates were 
reincubated at 37°C. Wells were observed at 12 and 24 h for a 
color change from blue to pink and for a reading of 50,000 
fluorescence units (FU). Fluorescence was measured in a Cytofluor  
 
 
 
 
Table 1. In vitro activity of Spondias mombin against 
Mycobacterium tuberculosis. 
 
Test agents M. tuberculosis % Inhibition 
SMi8-9 94.9 
SMi10-12 87.4 
SMi13 85.7 
SMi14 98.3 
SMi15 92.8 
SMi16 55.7 
SMi17 49.1 
SMi18 46.2 
SMi19-20 36.5 
SMi21 23.5 
SMi22 20.2 
SMJET 60.0 
Rifampin 99.7 
Isoniazid 91.4 
Mox 99.3 
streptomycin sulfate 99.7 
PA824 98.8 
 
Mycobacterium tuberculosis strain: H37RV. 
 inhibition of 90% was considered active. 
 Assays were run using 64 g/ml Spondias mombin. 
 
 
 
II microplate fluorometer (PerSeptive Biosystems, Framingham, 
Mass.) in bottom-reading mode with excitation at 530 nm and 
emission at 590 nm. If the B wells became pink by 24 h, reagent 
was added to the entire plate. If the well remained blue or 50,000 
FU was measured, additional M and B wells were tested daily until 
a color change occurred, at which time reagents were added to all 
remaining wells. Plates were then incubated at 37°C, and results 
were recorded at 24 h post-reagent addition. 
Percent inhibition was defined as 1 - (test well FU/mean FU of 
triplicate B wells) x 100. The lowest drug concentration effecting an 
inhibition of 90% was considered the MIC. 
 
 
RESULTS AND DISCUSSION  
 
The results of the phytochemical screening of the MeOH 
extract of plant sample revealed the presence of tannins, 
flavonoids, cardenolides, and anthraquinones while 
alkaloids were found absent. The semi-pure SMi15 gave 
positive Liebermann-Burchard test for a triterpene. Table 
1 shows the observed anti-Mtb activity of S. mombin 
column fractions in the in the microplate Alamar blue 
assay (MABA). SMi8-9, SMi14 and SMi15 demonstrated 
good potency of 94.9, 98.3 and 92.8% Inhibition, respec-
tively, against M. tuberculosis in a dose dependent 
manner compared with controls. The results reveal S. 
mombin as a promising natural product agent that can 
provide useful antitubercular drugs. 
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